Exchange: NASDAQ·Updated 08:21 PM EDT
QTRX logo

QTRXQuanterix Corp

$4.33
$0.56
(14.89%)
Today
Closed $4.32
$0.01
(0.23%)
Overnight
EarningsAug 6
Mkt Cap$203.5M
Vol3.6M
News
all
press releases
Quanterix Stock Is Popping In Pre-Market: Here's Why
Quanterix shares surged 5.28% in pre-market trading on Wednesday to $3.39, reversing the prior day's losses.read more...
Benzinga
News Placeholder
More News
News Placeholder
TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today
The small-cap stocks surged between 6% and 27% after hours on Tuesday.
Stocktwits
News Placeholder
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quanterix Corporation (Quanterix or the Company) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that on June 15, 2026, inducement grants (the Inducement Grants) were made to three employees in connection with...
Business Wire
News Placeholder
Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer
Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the appointment of Jason Faessler as the Companys new Chief Financial Officer, effective June 22. Faessler brings extensive finance...
Business Wire
News Placeholder
Quanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics
Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the appointment of Geoff Albrecht as Senior Vice President and General Manager of Diagnostics. This strategic hire underscores Quanterixs...
Business Wire
News Placeholder
Quanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that senior management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference being held in Miami, FL from June...
Business Wire
News Placeholder
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quanterix Corporation (Quanterix or the Company) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that on May 15, 2026, an inducement grant (the Inducement Grant) was made to Anthony Catalano in connection with...
Business Wire
News Placeholder
Quanterix Announces Planned Transition of Chief Financial Officer
Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that Vandana Sriram, its Chief Financial Officer (CFO) will depart the Company. A search for her successor is ongoing, and Ms. Sriram will...
Business Wire
News Placeholder
Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates
Quanterix (QTRX) delivered earnings and revenue surprises of -25.81% and -0.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Quanterix Releases Financial Results for the First Quarter of 2026
Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced financial results for the first quarter...
Business Wire
<
1
2
...
>

Advertisement|Remove ads.